Phase 1 Herpes Zoster (HZ) Clinical Trials
2 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety of Recombinant Herpes Zoster Vaccine for Healthy Individuals
Herpes Zoster (HZ)
Shanghai Institute Of Biological Products645 enrolled1 locationNCT06932523
Recruiting
Phase 1
Safety and Immunogenicity of the Recombinant Zoster Vaccine, LYB004 in Adults Aged 40 Years and Older
Herpes Zoster (HZ)
Guangzhou Patronus Biotech Co., Ltd.92 enrolled1 locationNCT06874842